InsidersTradesSigma
Total declarations
Company
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
9
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Coleman Craig E., Director. Officer active across 1 company, notably Universal Biosensors INC. Aggregated, 9 reports have been published. Breakdown: 9 buys · 0 sell. Total volume traded: €5.1m. History available since 1 November 2021. The latest transaction was filed on 27 May 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations9 total
1,421,293 shares@ US$0.112.5% of flowCommon StockSEC:0001104659-24-065367:0
Ideal exit: 21 Feb 2025 (T+270)
29,289,424 shares@ US$0.1572.2% of flowCommon StockSEC:0001104659-24-057126:0
Ideal exit: 26 Jan 2025 (T+270)
1,000,000 shares@ US$0.203.3% of flowCommon StockSEC:0001104659-24-038941:0
Ideal exit: 20 Dec 2024 (T+270)
100,000 shares@ US$0.220.4% of flowCommon StockSEC:0001104659-23-100218:0
Ideal exit: 7 Jun 2024 (T+270)
50,000 shares@ US$0.250.2% of flowCommon StockSEC:0001104659-22-119348:0
Ideal exit: 8 Aug 2023 (T+270)
200,000 shares@ US$0.281.0% of flowCommon StockSEC:0001104659-22-092425:0
Ideal exit: 14 May 2023 (T+270)
25,000 shares@ US$0.380.8% of flowCommon StockSEC:0001437749-22-015093:0
Ideal exit: 6 Mar 2023 (T+270)
48,620 shares@ US$0.481.9% of flowCommon StockSEC:0001437749-22-013957:0
Ideal exit: 18 Feb 2023 (T+270)
896,506 shares@ US$0.7348.7% of flowCommon StockSEC:0001104659-21-134747:0
Ideal exit: 29 Jul 2022 (T+270)
9 of 9 declarations
About Coleman Craig E.
Craig E. Coleman is a Director at Universal Biosensors Inc. As a board member, he contributes to the governance of the company and strategic decision-making. His expertise is an asset for the development of the organization in the biosensors sector.
